82 related articles for article (PubMed ID: 17060506)
1. Effects of angiotensin II on NO bioavailability evaluated using a catheter-type NO sensor.
Imanishi T; Kobayashi K; Kuroi A; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertension; 2006 Dec; 48(6):1058-65. PubMed ID: 17060506
[TBL] [Abstract][Full Text] [Related]
2. Effects of pioglitazone on nitric oxide bioavailability measured using a catheter-type nitric oxide sensor in angiotensin II-infusion rabbit.
Imanishi T; Kuroi A; Ikejima H; Kobayashi K; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertens Res; 2008 Jan; 31(1):117-25. PubMed ID: 18360026
[TBL] [Abstract][Full Text] [Related]
3. Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits.
Imanishi T; Ikejima H; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertens Res; 2008 Jun; 31(6):1199-208. PubMed ID: 18716369
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression.
Blendea MC; Jacobs D; Stump CS; McFarlane SI; Ogrin C; Bahtyiar G; Stas S; Kumar P; Sha Q; Ferrario CM; Sowers JR
Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E353-9. PubMed ID: 15494608
[TBL] [Abstract][Full Text] [Related]
5. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
Banday AA; Lokhandwala MF
Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
[TBL] [Abstract][Full Text] [Related]
6. Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes.
Imanishi T; Tsujioka H; Ikejima H; Kuroi A; Takarada S; Kitabata H; Tanimoto T; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertension; 2008 Sep; 52(3):563-72. PubMed ID: 18645051
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist combination on nitric oxide bioavailability and atherosclerotic change in Watanabe heritable hyperlipidemic rabbits.
Imanishi T; Kuroi A; Ikejima H; Kobayashi K; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
Hypertens Res; 2008 Mar; 31(3):575-84. PubMed ID: 18497479
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pharmacological modulation of nitroglycerin-induced impairment of nitric oxide bioavailability by a catheter-type nitric oxide sensor.
Imanishi T; Kuroi A; Ikejima H; Mochizuki S; Goto M; Akasaka T
Circ J; 2007 Sep; 71(9):1473-9. PubMed ID: 17721031
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats.
Carey RM; Howell NL; Jin XH; Siragy HM
Hypertension; 2001 Dec; 38(6):1272-7. PubMed ID: 11751702
[TBL] [Abstract][Full Text] [Related]
10. Chronic ANG II infusion increases NO generation by rat descending vasa recta.
Zhang Z; Rhinehart K; Solis G; Pittner J; Lee-Kwon W; Welch WJ; Wilcox CS; Pallone TL
Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H29-36. PubMed ID: 15331364
[TBL] [Abstract][Full Text] [Related]
11. Endothelial progenitor cell differentiation and senescence in an angiotensin II-infusion rat model.
Kobayashi K; Imanishi T; Akasaka T
Hypertens Res; 2006 Jun; 29(6):449-55. PubMed ID: 16940708
[TBL] [Abstract][Full Text] [Related]
12. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
Rosón MI; Della Penna SL; Cao G; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
J Cell Physiol; 2010 Jul; 224(1):41-8. PubMed ID: 20232302
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II-induced vascular dysfunction is mediated by the AT1A receptor in mice.
Ryan MJ; Didion SP; Mathur S; Faraci FM; Sigmund CD
Hypertension; 2004 May; 43(5):1074-9. PubMed ID: 15007032
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat.
Whaley-Connell A; Govindarajan G; Habibi J; Hayden MR; Cooper SA; Wei Y; Ma L; Qazi M; Link D; Karuparthi PR; Stump C; Ferrario C; Sowers JR
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E355-63. PubMed ID: 17440033
[TBL] [Abstract][Full Text] [Related]
15. Effect of tempol on altered angiotensin II and acetylcholine-mediated vascular responses in thoracic aorta isolated from rats with insulin resistance.
Viswanad B; Srinivasan K; Kaul CL; Ramarao P
Pharmacol Res; 2006 Mar; 53(3):209-15. PubMed ID: 16412660
[TBL] [Abstract][Full Text] [Related]
16. Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change.
Ikejima H; Imanishi T; Tsujioka H; Kuroi A; Kobayashi K; Shiomi M; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
J Hypertens; 2008 May; 26(5):964-72. PubMed ID: 18398339
[TBL] [Abstract][Full Text] [Related]
17. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
[TBL] [Abstract][Full Text] [Related]
18. Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers.
Gossmann J; Burkhardt R; Harder S; Lenz T; Sedlmeyer A; Klinkhardt U; Haak T; Geiger H; Scheuermann EH
Clin Pharmacol Ther; 2000 Nov; 68(5):501-9. PubMed ID: 11103753
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
Rehman A; Rahman AR; Rasool AH
J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
[TBL] [Abstract][Full Text] [Related]
20. Valsartan abolishes most of the memory-improving effects of intracerebroventricular angiotensin II in rats.
Braszko JJ
Clin Exp Hypertens; 2005 Nov; 27(8):635-49. PubMed ID: 16303640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
